- Country: USA
- Summary: Naloxone Oral Syringes
- UST Ref No: 128372310
- Deadline: 28 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: W81K00-26-Q-A022
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- THE PURPOSE OF SOLICITATION AMENDMENT 0002 IS TO EXTEND THE SOLICITATION TO 28 OCTOBER 2025 FOR THE NALOXONE 2MG/2ML ORAL SYRINGES.
The Department of Pharmacy at Brooke Army Medical Center (BAMC) is requesting a base plus 4 year (5 years total) contract for 1,413 Naloxone oral syringes annually.
Bidder Questions Due: 17 Oct 2025
Responses Due: 28 Oct 2025, 3:00 p.m., MST - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNaloxone Oral Syringes - USA Tender
The DEPT OF DEFENSE | DEPT OF THE ARMY, a Government sector organization in USA, has announced a new tender for Naloxone Oral Syringes. This tender is published on USARFP under UST Ref No: 128372310 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-28.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
